CDMO Profile

Oakwood Labs

Oakwood Labs Contract Manufacturing & Development (CDMO) Profile

Oakwood is a global leader in long acting injectable drug delivery through the use of our Chroniject patented technology. We offer end to end CDMO services from initial feasibility through GMP commercial manufacturing.

CDMO Services:
Finished Dosage Forms (Small Molecule Drugs) Lyophilized amps/vials Analytical Development; Drug Delivery System; Formulation Development; ICH Stability Testing; Process Development

Year Founded: 1997

Head Office: Oakwood Village, United States

Number of Facilities: 1-2

Facility locations: North America

Website: Visit the Oakwood Labs website

Linkedin: Connect on Linkedin

Current Capacity: Open for new capacity in our R&D and GMP facilities.

Sign up to the free weekly newsletter for all the latest news, resources and podcasts in contract manufacturing.  Register here

Experience the future of contract manufacturing

Join us at CDMO Live, 7-8 May 2025 in Rotterdam for an exclusive live event dedicated to contract manufacturing partnerships. Apply for your ticket.

INFOGRAPHIC

Download the latest infographic summarising key players in Small Molecule, Biologics and Cell & Gene Therapies.

Who do you rate?
Recommend a Supplier

Help us find the most innovative and trusted suppliers in Pharma and Biotech.